News

To date, CAR-T therapies have shown promise in early human clinical trials for the treatment of blood cancers and allogeneic CAR-Ts have the potential for use as off-the-shelf

rVSV-EBOV was originally developed by the Public Health Agency of Canada (PHAC) and is currently being evaluated in Phase I clinical trials. Merck Vaccines president Dr Julie Gerberding

The new five year agreement, which extends through December 2019, creates efficiencies for both companies by leveraging the strength of Omnicare as the nation’s largest institutional pharmacy and

Psoriasis is an immune mediated skin condition characterised by raised scaly lesions on the skin. It affects approximately 14 million people across Europe and about 125 million people

Opdivo is BMS’s investigational PD-1 (programmed death-1) immune checkpoint inhibitor, while FPA008 is Five Prime’s monoclonal antibody that inhibits colony stimulating factor-1 receptor (CSF1R). As part of the

The company has also notified the owner of the Reference Listed Drug of its filing. In November, Endo Pharmaceuticals Solutions, Bayer Intellectual Property and Bayer Pharma filed suit

Chimerasome is based on a single protein that can be assembled to form a spherical protein nanocage encapsulating drugs or nucleic acid therapeutics. It can be decorated with

Acromegaly is a syndrome that results when the anterior pituitary gland produces excess growth hormone (GH) after epiphyseal plate closure at puberty. Novartis Oncology president Bruno Strigini said:

Duaklir is a fixed-dose combination of Eklira (aclidinium bromide), a long-acting muscarinic-antagonist (LAMA), with the long-acting beta-agonist (LABA) formoterol. Administered by the Genuair dry powder inhaler device, the